UDI (Unique Device Identification) and patient safety latest regulatory developments
|
|
- Adela Helena Jones
- 6 years ago
- Views:
Transcription
1 UDI (Unique Device Identification) and patient safety latest regulatory developments Ulrike Kreysa, VP Healthcare, GS1 Global Office Medical Devices Innovation Program Munich, 14 October 2016
2 Agenda UDI what is it? Global standards to get ready for UDI across the world Regulatory developments beyond US FDA Imagine 2
3 UDI purpose Objective A common, worldwide system for product identification should eliminate differences between jurisdictions and offer significant benefits to manufacturers, users and/or patients, and regulatory authorities. 3
4 UDI system
5 A comparison UDI & 5
6 is like Munich & The October Fest 6
7 More than 90% of products in US FDA GUDID carry GS1 as UDI primary device identifier 7
8 What is GS1? GS1 is a neutral, not-for-profit standards organisation that helps companies do business across the world Member Organisations around the world - Developing standards for over 1 million companies worldwide - 25 industries served across 150 countries - Barcodes scanned more than 5 billion times a day globally
9 GS1 Healthcare: Voluntary, Global Healthcare User Group To lead the healthcare sector to the successful development and implementation of global standards by bringing together experts in healthcare to enhance patient safety and supply chain efficiencies.
10 Our vision The vision of GS1 Healthcare is to be the recognised, open and neutral source for regulatory agencies, trade organisations and other similar stakeholders seeking input and direction for global standards in healthcare for patient safety supply chain security & efficiency traceability product data 10
11 GS1 Healthcare: an expanding, committed community of globally engaged stakeholders and there are many more companies working with GS1 at a local level
12 and implementation by leading healthcare providers 12
13 GS1: global system of standards to ensure visibility 13
14 UDI & the GS1 system UDI in GS1 identification (identify) terms 14
15 UDI in GS1 data carrier terms Common industry practices All data carriers are for illustration only, not to scale and not in proportional size to one another. Please refer to GS1 General Specifications for detailed & up-to-date GS1 System information. UDI requirements may vary by geography -please refer to regional UDI regulations.
16 GDSN (Global Data Synchronisation Network) as an important enabler Data is registered in the GUDID by the Source Data Pool Manufacturers are able to provide data to any UDI database and their customers (hospitals, distributors, wholesalers, GPOs), with a single connection. 1
17 The value of trusted data 17
18 EU Medical Devices and IVD Regulations Status: - Q3 2012: EC proposals MD and IVD Regulations - April 2013: EC UDI Recommendation - Oct. 2015: Trilogue starting and ongoing - 15 June 2016: negotiated texts agreed and released - Q (tbc): publication Regulations OJUE Purpose: Medical Devices Identification system Open point(s)/upcoming dev.: - UDI specifications are part of the core of the Regulations - A lot of remaining questions on the EU DataBase (Eudamed) implementing acts expected - Some different approaches to US FDA - UDI assigning entities: GS1, HIBCC and ICCBBA until the EU Commission potentially designates others - traceability requirements - healthcare providers have to store the UDIs PP Database Dossier #: 200EUMD
19 Future Eudamed? EUDAMED European MD/IVD database Registrati on - Devices - Economic operators - SSCP Certificates - Issued - Suspended - Withdrawn - Refused - Restricted Vigilance - Serious incidents - FSCA - FSN - Corrective actions Clinical investigatio n - Sponsor - Purpose - Status - Approval - Summary? Market Surveillanc e - Measures taken by MS - Preventive health measures - Non compliant devices UDI Static data elements 19
20 Many open questions remain Connection of national databases to Eudamed Manufacturer versus labeler Obligation for healthcare institutions to implement Process for applying for exemptions? Basic UDI DI concept 20
21 21 England NHS Objectives: Deliver efficiency and productivity gains Improve data, information and transparency Re-think clinical engagement in procurement Improve trust capabilities in procurement Actions: Mandate through contracts GS1 standards GTIN, GLN and GDSN Create a single NHS GS1 data pool Define standards for eprocurement Establish standards for datasets/classification Put implementation support in place
22 Time for change 22
23 Leverage UDI benefits Pursue a global UDI strategy Gain business value from UDI Use a globally unique system for identification Develop a Global Data Governance approach Connect to multiple data recipients (incl. UDI Databases) UDI Build systems do more than check the UDI Regulatory box Leverage the UDI throughout the Supply /Patient Care Chain Create a win/win relationship with your partners on UDI data 23
24 a world where 24
25 the patient rights were reality, all the time! right route right caregiver right medical device right patient right time 25
26 Imagine a world where bedside scanning confirms that the patient gets the right product in the right dosage at the right time and the patient records captures all the details. where hospitals and pharmacies know the exact location of short-supply medical devices and drugs and when they can be delivered. where regulators can recall products with accuracy and speed from every point in the supply chain and there is no possibility of receiving a counterfeit product.
27 Huge cost savings and patient safety benefits when adopting a single global standard in healthcare 27 Implementing global standards across the entire healthcare supply chain could save 22,000-43,000 lives and avert 0.7 million to 1.4 million patient disabilities Rolling out such standards-based systems globally could prevent tens of billions of dollars worth of counterfeit drugs from entering the legitimate supply chain [We] estimate that healthcare cost could be reduced by $40 billion-$100 billion globally from the implementation of global standards Adopting a single set of global standards will cost significantly less than two (between 10-25% less cost to stakeholders) SOURCE: McKinsey report, Strength in unity: The promise of global standards in healthcare, October 2012
28 Let s move forward to achieve the highest quality care for all patients 2016 & beyond 28
29 Contact Details Ulrike Kreysa GS1 Global Office, Brussels E ulrike.kreyss@gs1.org T W
GS1 Guide on Unique Device Identification (UDI) implementation
GS1 Guide on Unique Device Identification (UDI) implementation This document aims at providing clarification to questions raised by the industry as well as implementation guidance on the use of GS1 standards.
More informationWelcome to our 29 th Global GS1 Healthcare Conference. Follow us on Twitter and tweet about the #GS1HCuae
Welcome to our 29 th Global GS1 Healthcare Conference Follow us on Twitter and tweet about the conference! @GS1Healthcare #GS1HCuae Welcome to the conference 29 th Global GS1 Healthcare Conference Dubai,
More informationWhere and how to start implementing GS1 standards in a hospital
Where and how to start implementing GS1 standards in a hospital Tania Snioch, GS1 Global Feargal Mc Groarty, National Centre for Hereditary Coagulation Disorders, St James s Hospital, Ireland WHY? GS1
More informationThe world of GS1 standards in healthcare. Chris Adcock GS1 Global Office
The world of GS1 standards in healthcare Chris Adcock GS1 Global Office Topics Background Where we are going Where we are today What this means to you Questions Background Topics Where we are going Where
More informationThe healthcare stakeholders expressed their strong support in the adoption of GS1 as the global standard best suited for their industry
The healthcare stakeholders expressed their strong support in the adoption of GS1 as the global standard best suited for their industry Implementing global standards across the entire healthcare supply
More informationGS1 Healthcare Newsletter
No. 25 Q4 2012 table of contents Special feature: GS1 Healthcare Conference Gathers in Lisbon 1 GS1 Healthcare takes the stage in Lisbon 1 McKinsey & Company reports on the benefits a single global standard
More informationGS1 Ireland Healthcare User Group (HUG) Information Day
GS1 Ireland Healthcare User Group (HUG) Information Day Overview on EU FMD regulation and unique identification requirements Geraldine Lissalde-Bonnet, GS1 Global Office 28 th March 2017 Overview on EU
More informationB.Braun: Global Regulatory Compliance Achieves Additional Benefits
TM CASE STUDY B.Braun: Global Regulatory Compliance Achieves Additional Benefits Challenge The healthcare landscape is experiencing a significant transformation. Today s patients are savvy consumers, demanding
More informationUnique Device Identifier (UDI) Labeling
INFORMATION SHEET Unique Device Identifier (UDI) Labeling On September 24, 2013, the United States Food and Drug Administration (FDA) released a final rule requiring that most medical devices distributed
More informationUniversity Health Network UDI Capture Work Group Case Study
LEARNING UDI COMMUNITY University Health Network UDI Capture Work Group Case Study WWW.AHRMM.ORG / LUC WORK GROUP TITLE: UDI Capture Work Group CASE STUDY PARTICIPANTS Wendy Watson, OR Supply Chain Manager
More informationGS1 Healthcare 2018 Strategic Priorities. January 2018
GS1 Healthcare 2018 Strategic Priorities January 2018 GS1 Healthcare 2018 Strategic Priorities Vision: To be the recognised, open and neutral source for regulatory agencies, trade organisations and other
More informationVIGILANZA E SORVEGLIANZA POST- COMMERCIALIZZAZIONE
VIGILANZA E SORVEGLIANZA POST- COMMERCIALIZZAZIONE VIGILANZA E SORVEGLIANZA POST-COMMERCIALIZZAZIONE Post-Market Surveillance dal punto di vista dell O.N in vista dei nuovi Regolamenti (MDR/IVDR) Francesco
More informationIMPLEMENTATION REALITY SESSION Unique Device Identification (UDI)
IMPLEMENTATION REALITY SESSION Unique Device Identification (UDI) Introductory Session AIDC & GDSN GS1 Healthcare Conference Mexico City 22 April 2015 UDI Implementation Reality Our Panel GS1 AIDC UDI
More informationMembership Registration Form. Company Details
Membership Registration Form This form allows you to become a voting or non-voting member of GS1 Healthcare, the global healthcare user group. GS1 Healthcare welcomes the following stakeholders as voting
More informationHealth Care/Pharmaceutical. GS1 Standards for Serialization and Visibility Within the U.S. Pharmaceutical Supply Chain
1 Health Care/Pharmaceutical GS1 Standards for Serialization and Visibility Within the U.S. Pharmaceutical Supply Chain 2 Health Care/Pharmaceutical: GS1 Standards for Serialization and Visibility Within
More informationMJ Wylie, Johnson & Johnson Nick Manzo, 1WorldSync
MJ Wylie, Johnson & Johnson Nick Manzo, 1WorldSync GDSN implementation, UDI Databases and product data for hospitals MJ Wylie, Global GDSN Deployment, Johnson & Johnson Nick Manzo, Global Senior Director
More informationHealthcare. Frequently Asked Questions (FAQs) by the Pharmaceutical Industry in Preparing for the U.S. DSCSA
Healthcare Frequently Asked Questions (FAQs) by the Pharmaceutical Industry in Preparing for the U.S. DSCSA Release 1.0, May 23 2017 Table of Contents 1 Introduction... 7 2 IDENTIFY: Questions about GS1
More informationAre Your Labels Compliant with European MDR? Presenters: Jay Crowley, USDM Ken Moir, NiceLabel Felix Klebe, Microscan Systems Date: October 11, 2017
Are Your Labels Compliant with European MDR? Presenters: Jay Crowley, USDM Ken Moir, NiceLabel Felix Klebe, Microscan Systems Date: October 11, 2017 Microscan Systems Inc. Label Compliance with the New
More informationIncorporating the Unique Device Identifier (UDI) into Health Care Delivery. Margaret Weiker, President, The Weiker Group
Incorporating the Unique Device Identifier (UDI) into Health Care Delivery Margaret Weiker, President, The Weiker Group Unique Device Identifier (UDI) Unique Device Identifier (UDI) an identifier that
More informationLUC UOU Examples Talk Track
LUC UOU Examples Talk Track (Slide 1): Welcome to the AHRMM Learning UDI Community. This presentation is intended to provide more information on potential use cases for the Unit of Use (also known as the
More informationInformation Management FAQ for UDI
White Paper Information Management FAQ for UDI 20 Questions & Answers about Complying with the FDA Requirement for Unique Device Identification (UDI) This document contains Confidential, Proprietary and
More informationGS1 Healthcare - Discussion paper on multi-market packs for pharmaceutical products
Purpose This GS1 Healthcare paper has been written to help demonstrate ways in which GS1 bar codes can be used to minimise the need for multiple bar codes to appear on product packaging while still enabling
More informationBC Health Authority Shared Services Organization Province-wide Shared Services. Better Value.
BC Health Authority Shared Services Organization Province-wide Shared Services. Better Value. Transforming Healthcare Supply Chains An update on progress in B.C. Presented to: National Healthcare Supply
More informationData as the key understanding all the options for business improvement Panel
Data as the key understanding all the options for business improvement Panel Mark Brommeyer, Manager Supply Chain, NEHTA Richard Bowen, Manager Data Systems and Reporting, HPV Steve Capel, Director Global
More informationOktober 4, 2011 Els C.M. van der Wilden-van Lier, MD, MPH Board of Governors / CMO ZGT. GS1 in Dutch Hospitals
Oktober 4, 2011 Els C.M. van der Wilden-van Lier, MD, MPH Board of Governors / CMO ZGT GS1 in Dutch Hospitals Overview ZGT in figures and key issues Healthcare 2011 Challenge Barcode Lessons learned in
More informationCAMD Implementation Taskforce
CAMD Implementation Taskforce Medical Devices Regulation/In-vitro Diagnostics Regulation (MDR/IVDR) Roadmap Overview and proposed terms of reference The Competent Authorities for Medical Devices (CAMD)
More informationUpdated EU Medical Device Regula2ons: What s In, What s Out, and What s Hot?
Updated EU Medical Device Regula2ons: What s In, What s Out, and What s Hot? Introduc2on EU Medical Device Overview Current Medical Device Direc2ves ü Governed by 3 directives (past 15-20 yrs): Polling
More informationThe challenges of software medical device regulation.
The challenges of software medical device regulation. david.grainger@mhra.gov.uk Introduction A brief history of software device regulation A look at the new device regulations 2 Current framework In Vitro
More informationAgreements on unique coding medical devices ADC
Agreements on unique coding medical devices ADC Final version 20 June 2017 2 Inhoud Management summary 6 1 Agreements concerning the introduction of unique coding for medical devices and drugs 8 1.1 Background
More informationGlobal Identification Numbers of the GS1 System
Global Identification Numbers of the GS1 System TM GS1 US TM is a not-for-profit, neutral organization dedicated to the adoption and implementation of standards-based, global supply chain solutions. A
More informationSt. James s Hospital leading global innovation in healthcare - a hospital wide approach to adopting GS1 standards
Healthcare provider implementation St. James s Hospital leading global innovation in healthcare - a hospital wide approach to adopting GS1 standards St. James s Hospital continues to lead the way by establishing
More informationDangers of Over-Regulation (or Under- Regulation) of Genetic Testing at EU level. David Barton
Dangers of Over-Regulation (or Under- Regulation) of Genetic Testing at EU level David Barton Department of Clinical Genetics Our Lady s Children s Hospital Dublin Background Diagnostic tests, known as
More informationGuide to Wholesaling and Brokering of Medicinal Products for Human Use in Ireland
Guide to Wholesaling and Brokering of Medicinal Products for Human Use in Ireland IA-G0008-5 17 JUNE 2017 This guide does not purport to be an interpretation of law and/or regulations and is for guidance
More informationIdentification and Marking of multi-market packs
Identification and Marking of multi-market packs Ask the expert Grant Courtney April 2015 Introduction Grant Courtney - Member of GS1 Healthcare Leadership Team - Co-author of the GS1 discussion paper
More informationPharmaceutical RFID: From Mandates to Endorsements and Laws
Pharmaceutical RFID: From Mandates to Endorsements and Laws By Sara Shah, Industry Analyst, RFID and M2M Research, ABI Research The healthcare industry s motivation for adopting RFID can be attributed
More informationReady or Not: The New Medical Device Regulations Are Here!
Ready or Not: The New Medical Device Regulations Are Here! Felicia R Cochran, PhD, CMPP TM feliciacochran@earthlink.net FR Cochran 1 General Disclaimers This presentation represents the knowledge, professional
More informationDrug Supply Chain Security Act Implementation Track and Trace Issues in 2017
Drug Supply Chain Security Act Implementation Track and Trace Issues in 2017 ILISA BG BERNSTEIN, PharmD, JD Deputy Director, Office of Compliance FDA/CDER Presented at: FDLI DQSA Conference November 15,
More informationGS1 STANDARDS IMPLEMENTATION
USAID GLOBAL HEALTH SUPPLY CHAIN PROGRAM PROCUREMENT AND SUPPLY MANAGEMENT GS1 STANDARDS IMPLEMENTATION Assessment of the USAID Supplier Base and the Ability of ARTMIS to Support GSI-compliant and Noncompliant
More informationMass Serialization and Traceability Implementation in the Pharma Industry. Mathieu Aman, Global Program Lead F. Hoffmann-La Roche Ltd, Switzerland
Mass Serialization and Traceability Implementation in the Pharma Industry Mathieu Aman, Global Program Lead F. Hoffmann-La Roche Ltd, Switzerland What drives the industry towards more traceability Strategic
More informationGS1 Data Source Healthcare. Web interface user manual for data recipients in healthcare
Web interface user manual for data recipients in healthcare Release 2.0, Ratified, 2 August 2017 Document Summary Document Item Document Name Current Value GS1 Data Source Healthcare Document Date 2 August
More informationTerumo Cardiovascular Systems and UDI; An Unexpected Voyage
Terumo Cardiovascular Systems and UDI; An Unexpected Voyage GHX 2013 proprietary Global Healthcare information. Exchange, Do not copy LLC. or All distribute. rights reserved. Agenda Overview of Terumo
More informationPerfect Order and Beyond
SMI Fall Forum 5/17/12 Curtis Dudley, ROi, Vice President of Integrated Business Solutions Dennis Black, BD, Director, e-business BD FORTUNE 500 company (#316) Locations in more than 50 countries Approximately
More informationAn Introduction to the Global Location Number (GLN)
An Introduction to the Global Location Number (GLN) Release 2.0, Sept 2017 Table of Contents 1 What is a Global Location Number?... 4 2 What is a GLN used for?... 4 3 Key Attribute of the GLN: Uniqueness...
More informationGuide to Scientific and Regulatory Advice for GXP activities
Guide to Scientific and Regulatory Advice for GXP activities ADV-G0019-1 7 OCTOBER 2017 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only.
More informationSE09. Track & Trace Solutions Jeff Bredemus Werner Electric
SE09 Track & Trace Solutions Jeff Bredemus Werner Electric Related Topics SE02 Balluff RFID SE03 Benefits of Image Based Barcode Reading SE08 Vision Solutions for the Food Ind. Solution Area 5 (Motion
More informationFlexible, robust solutions from BSI. An In Vitro Diagnostic Notified Body. Expertise and experience. IVD regulatory solutions
Flexible, robust solutions from BSI An In Vitro Diagnostic Notified Body Expertise and experience IVD regulatory solutions Updated May 2017 Your guide to the In Vitro Diagnostic Directive The purpose of
More informationIVD Regulation 2017/746
IVD Regulation 2017/746 Dr. Anne Van Nerom Famhp 2017-06-13 Recast-symposium Auditorium Storck (Eurostation II) Rue Juliette Wytsmanstraat 14 1050 Brussels Belgium T +32 2 642 51 11 F +32 2 642 50 01 email:
More informationImproving Patient Safety and Supply Chain Efficiency
GS1 Canada HEALTHCARE SUPPLIER IMPLEMENTATION GUIDE GS1 Global Location Number (GLN) All contents copyright GS1 Canada 2010 Page 1 of 29 Table of Contents EXECUTIVE SUMMARY... 3 ABOUT GS1... 4 INTRODUCTION
More informationDirect Marking for UDI Compliance. Microscan Systems Inc.
Direct Marking for UDI Compliance Microscan Systems Inc. Barbie LaBine Microscan Training Coordinator A Certified GS1 Standards Professional, Barbie LaBine has provided training to global medical device
More informationSource to consumer. Using GS1 standards in retail
Source to consumer Using GS1 standards in retail GS1 makes it possible for apparel and general merchandise companies to follow their products from the source to the consumer ensuring that the right product
More informationIMAGINE one world, one standard, one vision: improving PATIENT SAFETY
IMAGINE one world, one standard, one vision: improving PATIENT SAFETY Participants from around the world join the global GS1 Healthcare conference to: Share the latest news on industry and regulatory developments
More informationDistributor Traceability Updates Chris Anderson Cardinal Health Julie Kuhn H. D. Smith Scott Mooney - McKesson Heather Zenk AmerisourceBergen
Distributor Traceability Updates Chris Anderson Cardinal Health Julie Kuhn H. D. Smith Scott Mooney - McKesson Heather Zenk AmerisourceBergen Agenda Industry approach Suspect and illegitimate products
More informationVolunteering for Clinical Trials
Volunteering for Clinical Trials Volunteering for Clinical Trials When considering volunteering for a clinical trial, it is important to make an informed decision. Below are answers to frequently asked
More informationGlobal Medical Device Nomenclature: The Concept for Reducing Device-Related Medical Errors
Quality Assurance Global Medical Device Nomenclature: The Concept for Reducing Device-Related Medical Errors Anand K, Saini SK 1, Singh BK 2, Veermaram C Department of Pharmaceutics, Faculty of Pharmaceutical
More informationProject responsibilities
Project responsibilities Tallinn November 24th, 2017 Our Mission Falsified / counterfeit medicines are a serious risk for the citizens all around the world New legislation published on the 9th February
More informationNiccolo Machiavelli (1523)
Nothing is more difficult to undertake, more perilous to conduct or more uncertain in its outcome, than to take the lead in introducing a new order of things. For the innovator has for enemies all those
More informationSysmex Introduction and Africa Overview. Eric Osei General Manager West & Central Africa
Sysmex Introduction and Africa Overview Eric Osei General Manager West & Central Africa Sysmex Corporation, Japan Head Office Established 1968 Business Field Position in the IVD Kobe, Japan IVD, IT, Scientific
More information1. Council conclusions on strengthening the balance in the pharmaceutical systems in the EU and its Member States
PRESS 17/6/2016 PRESS RELEASE Council of the European Union 1. Council conclusions on strengthening the balance in the pharmaceutical systems in the EU and its Member States "The Council of the European
More informationVerification of Pharmaceutical Products at the Point of Dispense. An EFPIA update
Verification of Pharmaceutical Products at the Point of Dispense Speaker : Grant Courtney Event: GS1 Global Conference Location: Washington An EFPIA update 1 Who is EFPIA? The European Federation of Pharmaceutical
More informationMHRA GDP Symposium. Novotel London West, London 8 & 10 December #GMDPevents
MHRA GDP Symposium Novotel London West, London 8 & 10 December 2015 Complex Business Models - Outsourced Activities Presented by: Jacqueline Masayi, GDP Inspector Background Increased complexities of the
More informationCYTOTOXIC TRACEABILITY AND PATIENT WRISTBANDS
CYTOTOXIC TRACEABILITY AND PATIENT WRISTBANDS Pr Pascal BONNABRY Head of pharmacy Global GS1 Healthcare Conference Dubai, April 18, 2016 Introduction A full traceability of the medication process is the
More informationC&S Wholesale Grocers GDSN Initiative November 8, WorldSync & C&S
C&S Wholesale Grocers GDSN Initiative November 8, 2017 1WorldSync & C&S Agenda C&S Wholesale Grocers (C&S) - GDSN Initiative Overview Current Challenges GDSN Goals Attribute Requirements Measurements Overview
More informationImplications of the new MDR from a Product Testing and Certification Perspective
Implications of the new MDR from a Product Testing and Certification Perspective Helping You to Access Global Markets FAST and PREDICTABLY www.test-medical-devices.com 1 Hans Gerd Evering MDR - Implications
More informationHealthcare GTIN Allocation Rules
Healthcare GTIN Allocation Rules GS1 Global Healthcare User Group 03 October 2007, Final All contents copyright GS1 2007 Page 1 of 25 Document Summary Document Item Document Title Current Value Healthcare
More informationPEPPOL Demonstration of Technology. Steve Graham eprocurement Lead
PEPPOL Demonstration of Technology Steve Graham eprocurement Lead Background The NHS eprocurement strategy will establish the PEPPOL messaging standards and global GS1 coding throughout the healthcare
More informationfor the Smart Economy
18 Blockchain: The Force Multiplier for the Smart Economy 1 The world is filled with inefficiencies 3 DAYS Amount of time to sell a share of stock 12 DAYS Amount of time it takes for a bank to validate
More informationIHE Pharmacy Technical Framework Supplement. Uniform Barcode Processing (UBP) Rev. 1.0 Draft for Public Comment
Integrating the Healthcare Enterprise 5 IHE Pharmacy Technical Framework Supplement 10 Uniform Barcode Processing (UBP) 15 HL7 FHIR STU 3 Using Resources at FMM Level 2-5 Rev. 1.0 Draft for Public Comment
More informationAn industry perspective on medicines barcoding and bedside scanning
An industry perspective on medicines barcoding and bedside scanning Chris Dierickx Manager Business Development - Pfizer Global Supply Puurs Monday the 14 th of October 2013 Content Introduction Pfizer
More informationuseit in Cath Lab & IR
useit in Cath Lab & IR Benefits Saves money through: Expiration tracking, invoice reconciliation & reduced consignment liabilities. Increases revenue by: Automating charge capture to reduce lost charge
More informationInnovation and Improvement Project Manager - Institute for Innovation and Improvement
Innovation and Project Date: January 2017 Job Title : Innovation and Project Manager Department : Institute for Innovation and (i 3 ) Location : Waitemata District Health Board (office at NSH site) Reporting
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION RECOMMENDATION. of
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 12.5.2009 C(2009) 3200 final COMMISSION RECOMMENDATION of 12.5.2009 on the implementation of privacy and data protection principles in applications supported
More informationSt. James s Hospital
This Whitepaper documents the work conducted by St. James s Hospital in conjunction with their suppliers and key trading partners. The work is based on a best practice procurement model for Irish Healthcare
More informationGS1 Turkey Yeliz Geriş. İTS -Turkish Pharmaceutical Track and Trace System
GS1 Turkey Yeliz Geriş İTS -Turkish Pharmaceutical Track and Trace System What is İTS? İTS-Pharmaceutical Track & Trace System Project Phases Implementation Timeline Objectives Scope Labeling Workflow
More informationTHE COMMON TECHNICAL DOCUMENT: TAKING INDIAN NDA PROCESS TOWARDS GLOBALIZATION
Review Article Bhalodiya H. A.*, Boda J. M., Shah J. S., Patel P. B., Vaghela J. P. Department of Quality Assurance, S. J. Thakkar Pharmacy College, Rajkot-360005, Gujarat, India. *Corresponding author
More information1WorldSync DeCA Supplier Webinar. March 6 th, 2013
1WorldSync DeCA Supplier Webinar March 6 th, 2013 Agenda About DeCA GS1 Standards Overview Data Synchronization and GDSN DeCA Goals and Objectives DeCA Data Synchronization Initiative 2 About The Defense
More informationA Lever for Innovation in the UK
Public Procurement: A Lever for Innovation in the UK Dr. Gabriela Prada Associate Director, Health Innovation and Evaluation Calgary, September 26, 2008 Increased Realization that Innovation Policy Has
More informationMaximiliano Derecho. National Administration of Drugs, Food and Medical Devices (ANMAT), Argentina
Maximiliano Derecho National Administration of Drugs, Food and Medical Devices (ANMAT), Argentina Healthcare Conference 25/10/2016 EVOLUTION OF DRUGS TRACEABILITY IN ARGENTINA Dr. Maximiliano Derecho Legal
More informationEuropean Parliament resolution of 8 March 2011 on the revision of the General Product Safety Directive and market surveillance (2010/2085(INI))
P7_TA(2011)0076 General product safety and market surveillance European Parliament resolution of 8 March 2011 on the revision of the General Product Safety Directive and market surveillance (2010/2085(INI))
More informationImportance of GS1 Barcodes for Exports
Importance of GS1 Barcodes for Exports Fazlee Dhuny, Business Development Division July 2017 Agenda Importance of GS1 Barcodes when exporting Benefits of adopting GS1 barcodes vs proprietary barcodes GS1
More informationQuality Assurance of Investigational Medicinal Products. Sue McKenzie PPQA (A)
Quality Assurance of Investigational Medicinal Products Sue McKenzie PPQA (A) Agenda for Today IMP Regulations - CTD and Annex 13 Role of QP for IMP Challenges of IMP Manufacture for the QP IMP Regulations
More informationConformity Assessment of Own Brand Labelling
NBRG/306/06 Co-ordination of Title: Chapter: Conformity Assessment of Own Brand Labelling 2.5.5 Conformity assessment for particular product groups Text: Key words: manufacturer means the natural or legal
More informationCommission on Marketing and Advertising Task Force on Electronic Product Codes
International Chamber of Commerce The world business organization Department of Policy and Business Practices Commission on Marketing and Advertising Task Force on Electronic Product Codes ICC principles
More informationHL7 Plenary EHR In Canada
HL7 Plenary EHR In Canada September 11, 2006 Dennis Giokas Chief Technology Officer Canada Health Infoway, Inc Agenda Canada Health Infoway What is the EHR and It s Benefits Architecture and Standards
More informationEnvironment and resource efficiency Strategy and action plan 2016/17
Environment and resource efficiency Strategy and action plan 2016/17 Date: 27 June 2016 Version number: v1 Owner: David Jukes Approval route: NHSBSA Leadership Team Approval status: Approved 1. Introduction
More informationUpdate on Regulatory Environment- Europe Experience with 2007/47/EC M5 & Discussions on Possible Recast of EU Medical Device Regulations
Update on Regulatory Environment- Europe Experience with 2007/47/EC M5 & Discussions on Possible Recast of EU Medical Device Regulations Paul Brooks Vice President Healthcare, Americas Presentation to:
More informationInformation Governance Strategic Management Framework
Information Governance Strategic Management Framework 2016-2018 Susan Meakin Information Governance Manager June 2016 Information Governance DOCUMENT CONTROL: Version: 2 Ratified by: Health Informatics
More informationSynchronising Data: Proven Benefits for Your Company
Synchronising Data: Proven Benefits for Your Company Every company in the world has a database filled with information about the products they make, or sell, or buy. These databases act very much like a
More informationAndrea Mitchell. Medtronic
Andrea Mitchell Medtronic April 20, 2016 UNIQUE DEVICE IDENTIFICATION: Experiences with implementation of the U.S. FDA UDI Rule ANDREA MITCHELL MITG RA OPERATIONS MANAGER OUR MISSION, TENET #3: To strive
More information(Non-legislative acts) REGULATIONS
11.12.2010 Official Journal of the European Union L 327/13 II (Non-legislative acts) REGULATIONS COMMISSION REGULATION (EU) No 1169/2010 of 10 December 2010 on a common safety method for assessing conformity
More informationMEDICAL DEVICE CLINICAL INVESTIGATIONS AND ISO 14155
MEDICAL DEVICE CLINICAL INVESTIGATIONS AND ISO 14155 EXECUTIVE SUMMARY Medical device regulations around the world generally require manufacturers of most types of medical devices to supply data as part
More informationSPS HEALTH HELPING NHS TRUSTS MEET TODAY S CHALLENGES AND TOMORROW S DIGITAL GOALS
SPS HEALTH HELPING NHS TRUSTS MEET TODAY S CHALLENGES AND TOMORROW S DIGITAL GOALS SPS Health addresses pressure points without expensive upfront investment. TOMORROW S HEALTHCARE. TODAY PRACTICAL SOLUTIONS
More informationSerialisation End User View
Serialisation End User View Agenda What is serialisation? Why do we serialise? Regulatory landscape and challenges Approaches to serialisation WHAT IS SERIALISATION? Packaging Levels Lowest saleable unit
More informationRecords management policy. Document author Assured by Review cycle. Audit and Risk Committee. 1. Introduction Purpose or aim Scope...
Records management policy Board library reference Document author Assured by Review cycle P017 Head of Compliance Audit and Risk Committee 3 Years This document is version controlled. The master copy is
More informationThe content of a barcode and traceability of products. Stefanie De Rocker, Lead Barcodes & ECR Manager, GS1 Belgium & Luxembourg 21/11/2017
The content of a barcode and traceability of products Stefanie De Rocker, Lead Barcodes & ECR Manager, GS1 Belgium & Luxembourg 21/11/2017 Barcode? Identificatie number barcode Barcode Identification number
More informationEAN UCC standards for shared supply chain TRACEABILITY
EAN UCC standards for shared supply chain TRACEABILITY EAN Belgium Luxembourg Shared supply chain TRACEABILITY Page 1 TABLE OF CONTENTS 1. INTRODUCTION... 3 2. THE CONCEPT : TRACEABILITY... 5 3. THE EAN
More information